US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 8.480
  • +0.040+0.47%
Close Dec 13 16:00 ET
  • 8.380
  • -0.100-1.18%
Post 19:54 ET
452.63MMarket Cap-3.98P/E (TTM)

Zevra Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-291.98%-18.14M
-119.54%-19.11M
-299.63%-16.17M
-79.17%-33.54M
-262.12%-16.16M
29.86%-4.63M
-112.09%-8.7M
-13.85%-4.05M
-279.30%-18.72M
-426.18%-4.46M
Net income from continuing operations
-220.49%-33.23M
-674.39%-19.93M
-25.76%-16.62M
-72.00%-46.05M
-445.95%-19.89M
-56.70%-10.37M
89.30%-2.57M
-609.07%-13.22M
-212.94%-26.77M
312.73%5.75M
Operating gains losses
237.86%4.71M
-202.49%-5.82M
-360.38%-3.4M
100.37%57K
127.34%4.09M
-15,413.64%-3.41M
-8,265.22%-1.92M
641.49%1.31M
-194.09%-15.24M
-22,559.09%-14.96M
Depreciation and amortization
2,508.06%1.62M
1,902.56%1.56M
1,877.22%1.56M
6.57%1.01M
162.33%787K
-84.42%62K
-56.91%78K
21.54%79K
267.32%944K
368.75%300K
Other non cash items
1,208.45%929K
2,556.00%664K
602.38%295K
-98.73%227K
50.85%89K
9.23%71K
-99.86%25K
-16.00%42K
3,788.48%17.89M
-21.33%59K
Change In working capital
-103.08%-239K
77.25%-1.44M
-102.12%-148K
1,549.01%5.88M
-172.89%-2.54M
626.61%7.76M
-1,628.99%-6.33M
346.98%7M
-13.73%-406K
263.50%3.49M
-Change in receivables
-71.82%1.16M
89.66%-642K
1,801.89%9.07M
-34.05%-9.08M
-250.42%-7.45M
222.42%4.11M
-1,342.20%-6.21M
126.62%477K
-744.34%-6.77M
-2,436.26%-2.13M
-Change in inventory
-996.92%-583K
-1,439.19%-991K
-5,168.63%-2.59M
40.14%206K
112.03%16K
-73.03%65K
89.74%74K
--51K
--147K
---133K
-Change in prepaid assets
13.26%410K
21.19%-818K
-106.26%-44K
117.00%152K
-58.61%125K
-47.99%362K
52.71%-1.04M
132.01%703K
-8.36%-894K
-44.18%302K
-Change in payables and accrued expense
-181.04%-1.99M
-45.78%-1.3M
-290.46%-7.31M
255.48%11.13M
206.58%5.73M
288.13%2.45M
-179.66%-889K
889.30%3.84M
381.31%3.13M
140.23%1.87M
-Change in other current assets
927.27%91K
116.05%175K
53.75%123K
-51.58%321K
-70.57%171K
-110.38%-11K
208.00%81K
56.86%80K
398.50%663K
1,191.11%581K
-Change in other current liabilities
-9,150.00%-1.48M
473.81%482K
-232.92%-428K
82.94%-79K
-779.71%-469K
89.74%-16K
-84.24%84K
135.42%322K
-216.62%-463K
113.91%69K
-Change in other working capital
169.92%2.15M
5.16%1.65M
-33.25%1.02M
-14.57%3.23M
-122.71%-664K
120.44%798K
--1.57M
--1.53M
--3.78M
--2.92M
Cash from discontinued investing activities
Operating cash flow
-291.98%-18.14M
-119.54%-19.11M
-299.63%-16.17M
-79.17%-33.54M
-262.12%-16.16M
29.86%-4.63M
-112.09%-8.7M
-13.85%-4.05M
-279.30%-18.72M
-426.18%-4.46M
Investing cash flow
Cash flow from continuing investing activities
29.47%-31.35M
-100.38%-129K
184.27%14.79M
52.64%-17.39M
16,901.59%10.59M
-16,444.12%-44.46M
202.89%34.04M
-356.21%-17.56M
-136.53%-36.72M
99.59%-63K
Net PPE purchase and sale
--0
--0
--0
-218.28%-296K
-111.76%-72K
-514.29%-172K
-53.33%-23K
-81.25%-29K
8.82%-93K
-100.00%-34K
Net business purchase and sale
----
----
----
-115.76%-30.4M
----
----
----
----
---14.09M
--0
Net investment purchase and sale
29.20%-31.35M
-100.38%-129K
184.41%14.79M
159.05%13.31M
141,679.31%41.06M
-14,861.33%-44.28M
279.49%34.06M
-357.36%-17.53M
-46.13%-22.54M
99.81%-29K
Cash from discontinued investing activities
Investing cash flow
29.47%-31.35M
-100.38%-129K
184.27%14.79M
52.64%-17.39M
16,901.59%10.59M
-16,444.12%-44.46M
202.89%34.04M
-356.21%-17.56M
-136.53%-36.72M
99.59%-63K
Financing cash flow
Cash flow from continuing financing activities
146.64%64.77M
1,511.99%15.33M
132.45%1.22M
240.80%28.46M
2,047.08%5M
6,520.29%26.26M
-93.08%951K
20.77%-3.75M
-92.62%8.35M
91.05%-257K
Net issuance payments of debt
--0
5,159.01%16.29M
--0
94.74%24.9M
-36,600.00%-1.1M
1,310,400.00%26.21M
-102.52%-322K
1,220.00%112K
133.56%12.78M
82.35%-3K
Net common stock issuance
--64.67M
---71K
135.31%1.22M
156.30%2.66M
--6.11M
--0
--0
27.02%-3.45M
-110.16%-4.72M
--0
Proceeds from stock option exercised by employees
73.58%92K
----
----
-32.72%218K
-100.93%-1K
--53K
----
----
-98.95%324K
--108K
Net other financing activities
--0
----
----
2,196.97%692K
--0
--0
--1.11M
---415K
-100.04%-33K
-828.21%-362K
Cash from discontinued financing activities
Financing cash flow
146.64%64.77M
1,511.99%15.33M
132.45%1.22M
240.80%28.46M
2,047.08%5M
6,520.29%26.26M
-93.08%951K
20.77%-3.75M
-92.62%8.35M
91.05%-257K
Net cash flow
Beginning cash position
-40.69%39.26M
6.64%42.85M
-34.24%43.05M
-41.73%65.47M
-38.24%43.27M
-13.78%66.2M
-59.90%40.18M
-41.73%65.47M
2,499.40%112.35M
-46.72%70.06M
Current changes in cash
166.90%15.27M
-114.87%-3.91M
99.39%-155K
52.30%-22.46M
88.10%-569K
-238.90%-22.83M
212.16%26.28M
-108.92%-25.35M
-143.59%-47.08M
75.04%-4.78M
Effect of exchange rate changes
-381.37%-491K
219.03%319K
-169.23%-45K
-78.43%44K
84.66%349K
-780.00%-102K
---268K
--65K
--204K
--189K
End cash Position
24.89%54.04M
-40.69%39.26M
6.64%42.85M
-34.24%43.05M
-34.24%43.05M
-38.24%43.27M
-13.78%66.2M
-59.90%40.18M
-41.73%65.47M
-41.73%65.47M
Free cash flow
-277.94%-18.14M
-118.96%-19.11M
-296.78%-16.17M
-79.86%-33.83M
-260.99%-16.23M
27.56%-4.8M
-111.87%-8.73M
-14.15%-4.07M
-281.97%-18.81M
-419.77%-4.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -291.98%-18.14M-119.54%-19.11M-299.63%-16.17M-79.17%-33.54M-262.12%-16.16M29.86%-4.63M-112.09%-8.7M-13.85%-4.05M-279.30%-18.72M-426.18%-4.46M
Net income from continuing operations -220.49%-33.23M-674.39%-19.93M-25.76%-16.62M-72.00%-46.05M-445.95%-19.89M-56.70%-10.37M89.30%-2.57M-609.07%-13.22M-212.94%-26.77M312.73%5.75M
Operating gains losses 237.86%4.71M-202.49%-5.82M-360.38%-3.4M100.37%57K127.34%4.09M-15,413.64%-3.41M-8,265.22%-1.92M641.49%1.31M-194.09%-15.24M-22,559.09%-14.96M
Depreciation and amortization 2,508.06%1.62M1,902.56%1.56M1,877.22%1.56M6.57%1.01M162.33%787K-84.42%62K-56.91%78K21.54%79K267.32%944K368.75%300K
Other non cash items 1,208.45%929K2,556.00%664K602.38%295K-98.73%227K50.85%89K9.23%71K-99.86%25K-16.00%42K3,788.48%17.89M-21.33%59K
Change In working capital -103.08%-239K77.25%-1.44M-102.12%-148K1,549.01%5.88M-172.89%-2.54M626.61%7.76M-1,628.99%-6.33M346.98%7M-13.73%-406K263.50%3.49M
-Change in receivables -71.82%1.16M89.66%-642K1,801.89%9.07M-34.05%-9.08M-250.42%-7.45M222.42%4.11M-1,342.20%-6.21M126.62%477K-744.34%-6.77M-2,436.26%-2.13M
-Change in inventory -996.92%-583K-1,439.19%-991K-5,168.63%-2.59M40.14%206K112.03%16K-73.03%65K89.74%74K--51K--147K---133K
-Change in prepaid assets 13.26%410K21.19%-818K-106.26%-44K117.00%152K-58.61%125K-47.99%362K52.71%-1.04M132.01%703K-8.36%-894K-44.18%302K
-Change in payables and accrued expense -181.04%-1.99M-45.78%-1.3M-290.46%-7.31M255.48%11.13M206.58%5.73M288.13%2.45M-179.66%-889K889.30%3.84M381.31%3.13M140.23%1.87M
-Change in other current assets 927.27%91K116.05%175K53.75%123K-51.58%321K-70.57%171K-110.38%-11K208.00%81K56.86%80K398.50%663K1,191.11%581K
-Change in other current liabilities -9,150.00%-1.48M473.81%482K-232.92%-428K82.94%-79K-779.71%-469K89.74%-16K-84.24%84K135.42%322K-216.62%-463K113.91%69K
-Change in other working capital 169.92%2.15M5.16%1.65M-33.25%1.02M-14.57%3.23M-122.71%-664K120.44%798K--1.57M--1.53M--3.78M--2.92M
Cash from discontinued investing activities
Operating cash flow -291.98%-18.14M-119.54%-19.11M-299.63%-16.17M-79.17%-33.54M-262.12%-16.16M29.86%-4.63M-112.09%-8.7M-13.85%-4.05M-279.30%-18.72M-426.18%-4.46M
Investing cash flow
Cash flow from continuing investing activities 29.47%-31.35M-100.38%-129K184.27%14.79M52.64%-17.39M16,901.59%10.59M-16,444.12%-44.46M202.89%34.04M-356.21%-17.56M-136.53%-36.72M99.59%-63K
Net PPE purchase and sale --0--0--0-218.28%-296K-111.76%-72K-514.29%-172K-53.33%-23K-81.25%-29K8.82%-93K-100.00%-34K
Net business purchase and sale -------------115.76%-30.4M-------------------14.09M--0
Net investment purchase and sale 29.20%-31.35M-100.38%-129K184.41%14.79M159.05%13.31M141,679.31%41.06M-14,861.33%-44.28M279.49%34.06M-357.36%-17.53M-46.13%-22.54M99.81%-29K
Cash from discontinued investing activities
Investing cash flow 29.47%-31.35M-100.38%-129K184.27%14.79M52.64%-17.39M16,901.59%10.59M-16,444.12%-44.46M202.89%34.04M-356.21%-17.56M-136.53%-36.72M99.59%-63K
Financing cash flow
Cash flow from continuing financing activities 146.64%64.77M1,511.99%15.33M132.45%1.22M240.80%28.46M2,047.08%5M6,520.29%26.26M-93.08%951K20.77%-3.75M-92.62%8.35M91.05%-257K
Net issuance payments of debt --05,159.01%16.29M--094.74%24.9M-36,600.00%-1.1M1,310,400.00%26.21M-102.52%-322K1,220.00%112K133.56%12.78M82.35%-3K
Net common stock issuance --64.67M---71K135.31%1.22M156.30%2.66M--6.11M--0--027.02%-3.45M-110.16%-4.72M--0
Proceeds from stock option exercised by employees 73.58%92K---------32.72%218K-100.93%-1K--53K---------98.95%324K--108K
Net other financing activities --0--------2,196.97%692K--0--0--1.11M---415K-100.04%-33K-828.21%-362K
Cash from discontinued financing activities
Financing cash flow 146.64%64.77M1,511.99%15.33M132.45%1.22M240.80%28.46M2,047.08%5M6,520.29%26.26M-93.08%951K20.77%-3.75M-92.62%8.35M91.05%-257K
Net cash flow
Beginning cash position -40.69%39.26M6.64%42.85M-34.24%43.05M-41.73%65.47M-38.24%43.27M-13.78%66.2M-59.90%40.18M-41.73%65.47M2,499.40%112.35M-46.72%70.06M
Current changes in cash 166.90%15.27M-114.87%-3.91M99.39%-155K52.30%-22.46M88.10%-569K-238.90%-22.83M212.16%26.28M-108.92%-25.35M-143.59%-47.08M75.04%-4.78M
Effect of exchange rate changes -381.37%-491K219.03%319K-169.23%-45K-78.43%44K84.66%349K-780.00%-102K---268K--65K--204K--189K
End cash Position 24.89%54.04M-40.69%39.26M6.64%42.85M-34.24%43.05M-34.24%43.05M-38.24%43.27M-13.78%66.2M-59.90%40.18M-41.73%65.47M-41.73%65.47M
Free cash flow -277.94%-18.14M-118.96%-19.11M-296.78%-16.17M-79.86%-33.83M-260.99%-16.23M27.56%-4.8M-111.87%-8.73M-14.15%-4.07M-281.97%-18.81M-419.77%-4.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.